CLINICAL_TRIALS
trial_result
· 2021-02-26
Clinical Trial Update: Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 [Phase 3]
Summary
Phase 3 trial update evaluating DWJ1506 and DWJ1507 for dyslipidemias.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Dyslipidemias | Phase 3 | Status: UNKNOWN